Skip to main content
The Markets by Proactive
Go to Proactive UK
Proactive UK has moved. Proactive’s coverage of London’s small caps continues on proactiveinvestors.com Go there →
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Coverage of London’s small caps continues on proactiveinvestors.com
Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK

Pharma & Biotech

PRE-MARKET MOVERS: Smartphone giant BlackBerry leaps ahead of bell after quarterly results

CarMax Inc and PayPal Holdings Inc are also stocks trending ahead of the Wall Street start..

With US stocks seen starting higher, several stocks are in focus, including mobile phone and tech giant BlackBerry Ltd (NYSE:BB), which saw shares add 1.71% to US$11.90 in New York before the bell.

It came as the group unveiled a quarterly loss to end May on Friday, compared with a profit a year ago after it received a one-time arbitration payment of US$940mln from chipmaker Qualcomm Inc (NASDAQ:QCOM).

The net loss for the three months was US$60mln, or 11 cents per share, compared with a profit of US$671mln, or US$1.23 per share, a year earlier.

Also in pre-market deals, PayPal Holdings Inc (NASDAQ:PYPL), the payment processing titan, saw shares shed 0.023% to US$85.95 in pre-market, after the company unveiled an acquisition.

The group has agreed to acquire a fraud prevention technology company based in California called Simility for US$120mln in cash.

PayPal wants to offer small online merchants the same capabilities of the bigger e-commerce players.

Elsewhere, CarMax Inc (NYSE:KMX) shares shed 0.070% before the bell, having closed 2.43% lower on Thursday, as it posted first-quarter numbers.

Net earnings increased 12.7% to US$238.7mln and net earnings per diluted share increased 17.7% to US$1.33, while net sales and operating revenues increased 5.5% to US$4.79bn, the company revealed.

Bristol Myers Squibb Co (NYSE:BMY) shares are up 0.57% in pre-market to US$54.25 after the all-powerful FDA accepted an application to use Bristol's Opdivo (nivolumab) in combination with low-dose Yervoy (ipilimumab) to terat lung cancer in some patients.

This is the first application for a I-O/I-O combination regimen for lung cancer to be accepted by the US FDA (Food and Drug Administration).

Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK